Meeting Details

Date: Friday, September 25, 2026

Time: 10:00 A.M. (IST)

Location: Held through Video Conferencing/Other Audio Visual Means (VC/OAVM)

Type of Meeting: Thirty Fifth Annual General Meeting

Summary of Proceedings and Resolutions

The meeting was convened in accordance with guidelines from the Ministry of Corporate Affairs (MCA), the Companies Act, 2013, and SEBI Listing Regulations.

The Chairman, Mr. C. C. Paarthipan, confirmed the requisite quorum was present. The following key updates and proposed resolutions were presented:

Management Updates:

  • The Chairman informed shareholders of the appointments of Mr. Ashok Partheeban and Mr. Vivek Partheeban as Directors and Vice-Chairmen, and Dr. K. C. John and Ms. Susan Mathew as Non-Executive Independent Directors, which were approved by shareholders via Postal Ballot on January 31, 2026.
  • The proposed appointment of Mr. D. Muralidharan as Whole-Time Director for two years was announced.
  • The proposed re-appointment of Dr. Sridhar Ganesan as Managing Director for a further period of two years was announced.
  • Speeches were delivered by the Chairman, Dr. Sridhar Ganesan (Managing Director), Mr. Vivek Partheeban (on the Regulated Markets business), and Mr. D. Muralidharan (Whole-Time Director & CFO) on the company's financial performance and operations for FY 2025-26.

List of Resolutions for Voting:

The following resolutions, as per the AGM notice, were subject to voting:

Ordinary Business:

1. Adoption of Financial Statements (Ordinary Resolution)

2. Declaration of Final Dividend and Ratification of Interim Dividend (Ordinary Resolution)

3. Retirement by rotation and re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) (Ordinary Resolution)

Special Business:

4. Re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) as the Managing Director (Special Resolution)

5. Continuation of Mr. C. C. Paarthipan (DIN: 01218784) as the Chairman and Non-Executive, Non-Independent Director (Special Resolution)

6. Appointment of Mr. D Muralidharan (DIN: 08301904) as a Whole-Time Director (Special Resolution)

Voting Process

The voting process was conducted electronically:

  • Remote e-Voting: Was available to shareholders between September 22, 2026, and September 24, 2026.
  • E-Voting at the AGM: Members present at the virtual AGM who had not cast their votes remotely were provided an opportunity to cast their votes electronically within 15 minutes from the conclusion of the meeting.

The document explicitly states that the detailed, consolidated voting results will be filed separately with the exchanges in the format prescribed under Regulation 44(3) of the SEBI LODR Regulations and are not included in this submission.

Other Procedural Information

  • The Company Secretary, Mr. Venkatram G, confirmed that the requisite registers and disclosures were available for member inspection.
  • The Audited Standalone and Consolidated Financial Statements for the year ended March 31, 2026, and the Annual Report were taken as read.
  • The Statutory Audit Report and Secretarial Audit Report were confirmed to be free from qualifications and thus taken as read under Section 145 of the Companies Act, 2013.
  • A Q&A session was held where queries from one shareholder were addressed.
  • The meeting commenced at 10:00 A.M. and concluded at 10:51 A.M.

Compliance and Signatories

The disclosure is made in compliance with SEBI LODR Regulation 30. The letter is signed by Venkatram G, General Counsel & Company Secretary (Membership No. A23989), on behalf of Caplin Point Laboratories Limited.